Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;31(5):1-14.
doi: 10.1002/rmv.2209. Epub 2020 Dec 30.

The virome in early life and childhood and development of islet autoimmunity and type 1 diabetes: A systematic review and meta-analysis of observational studies

Affiliations
Review

The virome in early life and childhood and development of islet autoimmunity and type 1 diabetes: A systematic review and meta-analysis of observational studies

Clare L Faulkner et al. Rev Med Virol. 2021 Sep.

Abstract

Viruses are postulated as primary candidate triggers of islet autoimmunity (IA) and type 1 diabetes (T1D), based on considerable epidemiological and experimental evidence. Recent studies have investigated the association between all viruses (the 'virome') and IA/T1D using metagenomic next-generation sequencing (mNGS). Current associations between the early life virome and the development of IA/T1D were analysed in a systematic review and meta-analysis of human observational studies from Medline and EMBASE (published 2000-June 2020), without language restriction. Inclusion criteria were as follows: cohort and case-control studies examining the virome using mNGS in clinical specimens of children ≤18 years who developed IA/T1D. The National Health and Medical Research Council level of evidence scale and Newcastle-Ottawa scale were used for study appraisal. Meta-analysis for exposure to specific viruses was performed using random-effects models, and the strength of association was measured using odds ratios (ORs) and 95% confidence intervals (CIs). Eligible studies (one case-control, nine nested case-control) included 1,425 participants (695 cases, 730 controls) and examined IA (n = 1,023) or T1D (n = 402). Meta-analysis identified small but significant associations between IA and number of stool samples positive for all enteroviruses (OR 1.14, 95% CI 1.00-1.29, p = 0.05; heterogeneity χ2 = 1.51, p = 0.68, I2 = 0%), consecutive positivity for enteroviruses (1.55, 1.09-2.20, p = 0.01; χ2 = 0.19, p = 0.91, I2 = 0%) and number of stool samples positive specifically for enterovirus B (1.20, 1.01-1.42, p = 0.04; χ2 = 0.03, p = 0.86, I2 = 0%). Virome analyses to date have demonstrated associations between enteroviruses and IA that may be clinically significant. However, larger prospective mNGS studies with more frequent sampling and follow-up from pregnancy are required to further elucidate associations between early virus exposure and IA/T1D.

Keywords: childhood; islet autoimmunity; next-generation sequencing; type 1 diabetes; virome.

PubMed Disclaimer

Conflict of interest statement

This work was supported by the National Health and Medical Research Council Practitioner fellowship APP1136735 (to Maria E. Craig), the Juvenile Diabetes Research Foundation International Postdoctoral Fellowship 3‐PDF‐2020‐940‐A‐N and the Australian Diabetes Society Lindsey Baudinet Award (to Ki Wook Kim). The authors would like to thank Professors Ondrej Cinek and Kendra Vehik for providing supplementary raw data for inclusion in this systematic review.

The author declares that there is no conflict of interests.

Figures

FIGURE 1
FIGURE 1
Flow diagram of study selection
FIGURE 2
FIGURE 2
Individual and summary odds ratios for positivity for any vertebrate‐infecting virus in children with islet autoimmunity (IA) versus no IA, with stool versus plasma subgroup analysis. All results based on rates of virus positivity as detected by metagenomic next‐generation sequencing. No associations were found between virus positivity in stool or plasma and childhood IA
FIGURE 3
FIGURE 3
Individual and summary odds ratios for number of samples positive for enterovirus (EV) in children with islet autoimmunity (IA) versus no IA, with stool versus plasma subgroup analysis. All results based on rates of virus positivity as detected by metagenomic next‐generation sequencing. An association was found between childhood IA and number of stool samples positive for EV (odds ratio 1.14; 95% confidence interval 1.00–1.29, p = 0.05; heterogeneity χ 2 = 0.50, p = 0.68, I 2 = 0%), but not the number of plasma samples positive for EV
FIGURE 4
FIGURE 4
Individual and summary odds ratios (ORs) for number of stool samples positive for enterovirus B (EV‐B) in children with islet autoimmunity (IA) versus no IA. All results based on rates of virus positivity as detected by metagenomic next‐generation sequencing. An association was found between number of stool samples positive for EV‐B and IA (OR, 1.20; 95% confidence interval 1.01–1.42, p = 0.04; heterogeneity χ 2 = 0.03, p = 0.86, I 2 = 0%)
FIGURE 5
FIGURE 5
Individual and summary odds ratios (ORs) for studies examining positivity for enterovirus (EV) in ≥2 consecutive stool samples in children with islet autoimmunity (IA) versus no IA. All results based on rates of virus positivity as detected by metagenomic next‐generation sequencing. An association was found between consecutive EV shedding and childhood IA (OR 1.55, 95% confidence interval 1.09–2.20, p = 0.01; heterogeneity χ 2 = 0.10, p = 0.91, I 2 = 0%)

Similar articles

Cited by

References

    1. International Diabetes Foundation . IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Foundation; 2019.
    1. Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964‐1974. 10.2337/dc15-1419. - DOI - PMC - PubMed
    1. Ziegler A‐G, Kick K, Bonifacio E, et al. Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. J Am Med Assoc. 2020;323(4):339‐351. 10.1001/jama.2019.21565. - DOI - PMC - PubMed
    1. Pociot F, Lernmark Å. Genetic risk factors for type 1 diabetes. Lancet. 2016;387(10035):2331‐2339. 10.1016/s0140-6736(16)30582-7. - DOI - PubMed
    1. Hippich M, Beyerlein A, Hagopian WA, et al. Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes. 2019;68(4):847‐857. 10.2337/db18-0882. - DOI - PMC - PubMed